Global medical aesthetics company Classis announced on the 13th that it recorded consolidated sales of KRW 336.8 billion and operating profit of KRW 170.6 billion in 2025. Sales increased 38% and operating profit increased 39% year-over-year, resulting in an operating profit margin of 50.7%. This performance exceeds the average growth rate of the past three years, demonstrating that its product, regional, and sales channel diversification strategy served as a growth driver.
In particular, fourth-quarter sales reached KRW 93.4 billion, surpassing KRW 90 billion for the first time on a quarterly basis, and operating profit also surpassed KRW 50 billion, demonstrating continued, step-by-step growth. Overseas sales reached KRW 65.7 billion, a 33% year-over-year increase, accounting for 70% of total sales. This performance was driven by an expansion of the equipment installed base in North America and Europe, and increased sales of consumables in Asia.
Classis is transitioning to a direct management system in the Central and South American market through the acquisition of a local Brazilian agency. Following the transaction, Classis expects to directly recognize local sales and profits and expand its market share by strengthening customer service.
In 2026, the company aims for further growth, with sales guidance of up to KRW 510 billion, based on the effects of direct management conversion in South America and Japan, expansion of Shrink and Volumer into China and the US, expansion of market share in Europe, and growth in new equipment and home devices.
A Classis official stated, “This year, we aim to achieve sales of up to 510 billion won based on various growth engines by product and region,” adding, “We expect Volnummer to become a global mega-hit product, and we plan to continue to pursue direct management conversion and the launch of new equipment.”
- See more related articles
You must be logged in to post a comment.